| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.28468 |
| P698 | PubMed publication ID | 23999999 |
| P50 | author | Jun Ma | Q50066716 |
| Ling-Long Tang | Q70838352 | ||
| Xu Liu | Q108917280 | ||
| P2093 | author name string | Li Li | |
| Rui Guo | |||
| Ying Sun | |||
| Wei Jiang | |||
| Na Liu | |||
| Yan-Ping Mao | |||
| Qing-Mei He | |||
| William C S Cho | |||
| Li-Zhi Liu | |||
| Yi-Kan Cheng | |||
| Rui-Xue Cui | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1359-1368 | |
| P577 | publication date | 2013-09-30 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma | |
| P478 | volume | 134 |
| Q61798410 | A mathematical model as a tool to identify microRNAs with highest impact on transcriptome changes |
| Q52846340 | Applications of Extracellular RNAs in Oncology. |
| Q37403811 | Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment |
| Q41912362 | Characterization of dual PTEN and p53-targeting microRNAs identifies microRNA-638/Dnm2 as a two-hit oncogenic locus. |
| Q91895987 | Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis |
| Q37639778 | Circulating microRNAs Correlated with Bone Loss Induced by 45 Days of Bed Rest |
| Q41753919 | Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma |
| Q37327584 | Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF. |
| Q55362409 | Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma. |
| Q38702727 | Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance |
| Q26744487 | Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring Cells |
| Q90383404 | Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis |
| Q92909151 | Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma |
| Q59811500 | Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer |
| Q35788900 | Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma |
| Q90240770 | Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer |
| Q64911477 | Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma. |
| Q50635301 | Interaction between miR-572 and PPP2R2C, and their effects on the proliferation, migration, and invasion of nasopharyngeal carcinoma (NPC) cells. |
| Q92714808 | Knockdown of miR-572 suppresses cell proliferation and promotes apoptosis in renal cell carcinoma cells by targeting the NF2/Hippo signaling pathway |
| Q90424182 | Methylation‑associated silencing of miR‑638 promotes endometrial carcinoma progression by targeting MEF2C |
| Q37645814 | MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1. |
| Q38628576 | MicroRNA expression in bone marrow-derived human multipotent Stromal cells |
| Q55394876 | MicroRNA-328 inhibits migration and epithelial-mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells. |
| Q92923049 | MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma |
| Q34168445 | MicroRNAs as potential biomarkers for gastric cancer |
| Q34572800 | MicroRNAs in nasopharyngeal carcinoma |
| Q38996028 | Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review |
| Q49887992 | Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis. |
| Q35791145 | Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. |
| Q37605740 | Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer |
| Q38441574 | Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer |
| Q33947851 | Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers |
| Q38214481 | Point-of-care diagnostic tools to detect circulating microRNAS as biomarkers of disease |
| Q36133994 | Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis |
| Q35822555 | Robust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers |
| Q37369075 | Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy |
| Q37564513 | Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma |
| Q47405806 | Serum, plasma and saliva biomarkers for head and neck cancer. |
| Q91707587 | Specific miRNA expression profile in the blood serum of cardiac myxoma patients |
| Q49328438 | Study of miR-10b regulatory mechanism for epithelial-mesenchymal transition, invasion and migration in nasopharyngeal carcinoma cells |
| Q64234672 | Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma |
| Q34610984 | The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy |
| Q42375073 | The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma |
| Q35043716 | The role of microRNAs in nasopharyngeal carcinoma |
| Q90025312 | Unification of miRNA and isomiR research: the mirGFF3 format and the mirtop API |
| Q36020966 | Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression |
| Q58758617 | hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis |
| Q36772022 | miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways |
| Q37194235 | miR-638 suppresses DNA damage repair by targeting SMC1A expression in terminally differentiated cells |
Search more.